Cited 0 times in
First-line pembrolizumab plus chemotherapy versus chemotherapy in advanced esophageal cancer: Longer-term efficacy, safety, and quality-oflife results from the phase 3 KEYNOTE-590 study
DC Field | Value | Language |
---|---|---|
dc.contributor.author | 조병철 | - |
dc.date.accessioned | 2023-06-02T00:54:41Z | - |
dc.date.available | 2023-06-02T00:54:41Z | - |
dc.date.issued | 2022-02 | - |
dc.identifier.issn | 0732-183X | - |
dc.identifier.uri | https://ir.ymlib.yonsei.ac.kr/handle/22282913/194523 | - |
dc.description.statementOfResponsibility | restriction | - |
dc.language | English | - |
dc.publisher | American Society of Clinical Oncology | - |
dc.relation.isPartOf | JOURNAL OF CLINICAL ONCOLOGY | - |
dc.rights | CC BY-NC-ND 2.0 KR | - |
dc.title | First-line pembrolizumab plus chemotherapy versus chemotherapy in advanced esophageal cancer: Longer-term efficacy, safety, and quality-oflife results from the phase 3 KEYNOTE-590 study | - |
dc.type | Article | - |
dc.contributor.college | College of Medicine (의과대학) | - |
dc.contributor.department | Dept. of Internal Medicine (내과학교실) | - |
dc.contributor.googleauthor | Jean-Philippe Metges | - |
dc.contributor.googleauthor | Ken Kato | - |
dc.contributor.googleauthor | Jong-Mu Sun | - |
dc.contributor.googleauthor | Manish A. Shah | - |
dc.contributor.googleauthor | Peter C. Enzinger | - |
dc.contributor.googleauthor | Antoine Adenis | - |
dc.contributor.googleauthor | Toshihiko Doi | - |
dc.contributor.googleauthor | Takashi Kojima | - |
dc.contributor.googleauthor | Zhigang Li | - |
dc.contributor.googleauthor | Sung-Bae Kim | - |
dc.contributor.googleauthor | Byoung Chul Cho | - |
dc.contributor.googleauthor | Wasat Mansoor | - |
dc.contributor.googleauthor | Shau-Hsuan Li | - |
dc.contributor.googleauthor | Patrapim Sunpaweravong | - |
dc.contributor.googleauthor | MARIA ALSINA | - |
dc.contributor.googleauthor | Gary L Buchschacher | - |
dc.contributor.googleauthor | Jimin Wu | - |
dc.contributor.googleauthor | Sukrut Shah | - |
dc.contributor.googleauthor | Pooja Bhagia | - |
dc.contributor.googleauthor | Lin Shen | - |
dc.identifier.doi | 10.1200/JCO.2022.40.4_suppl.241 | - |
dc.contributor.localId | A03822 | - |
dc.relation.journalcode | J01331 | - |
dc.identifier.eissn | 1527-7755 | - |
dc.identifier.url | https://ascopubs.org/doi/10.1200/JCO.2022.40.4_suppl.241 | - |
dc.contributor.alternativeName | Cho, Byoung Chul | - |
dc.contributor.affiliatedAuthor | 조병철 | - |
dc.citation.volume | 40 | - |
dc.citation.number | 4 suppl | - |
dc.citation.startPage | 241 | - |
dc.identifier.bibliographicCitation | JOURNAL OF CLINICAL ONCOLOGY, Vol.40(4 suppl) : 241, 2022-02 | - |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.